Program Goals Overview Is NEDA a Reasonable Target?

Slides:

Advertisements

Similar presentations

Where Are We on the Path to Elimination of Chronic Hepatitis C?

Advertisements

Systemic Lupus Erythematosus

Diabetic Dyslipidemia in Practice

Engaging the INSULIN-TREATED T2DM Patient: the Importance of Real-World Data.

Challenges and Opportunities in the Management of ANCA-Associated Vasculitis.

Update on the Diagnosis and Management of CTEPH in Latin America

Program Themes. Consulting on Common Concerns in PAH: How Would You Manage These Patients?

Gout Management.

Improving the Diagnosis and Treatment of Seizures in Long-term Care

Program Goals Teriflunomide: Pooled Safety Data.

Updates in Hodgkin Lymphoma

Glaucoma Progression.

Best Practices in Huntington Disease

Modifying Disease Course in Alzheimer's Disease

What Predicts Disability Progression in Multiple Sclerosis?

Current Controversies in Multiple Sclerosis Management

Amyloid Imaging for Alzheimer's Disease in Practice

How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients

Bone Biology and Osteoporosis: Back to the Basics

Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.

Panelists. Unique Perspectives on the Cost Burden of Diabetes in the United States.

Treating Transplant-Ineligible Patients With Multiple Myeloma

Innovative Insulin Combinations: A New strategy for the Person With T2DM.

The Resurgence of Topical Treatments Across a Spectrum of Psoriasis

Aligning Patients and Clinicians: Optimizing Outcomes in Metastatic NSCLC.

Challenges in Managing Progressive Multiple Sclerosis

A Focus on Polycythemia Vera for Nurse Practitioners and Physician Assistants.

Talking to Patients About Diabetes Management

Are We Closer to Personalized Medicine in MS?

The future of urate-lowering strategies for gout

Team-Based Perspectives on Successful Approaches in Treating Obesity

Seizures in the Elderly: Treatment and Special Considerations

The Nurse View: Targeted Therapies for the Patient With Metastatic Colorectal Cancer.

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.

Should I Stay or Should I Go?

Targeting Osteoporosis Therapies to Patients at Highest Risk for Fracture.

Managing Adverse Events With New Oral Therapies in CLL

Charting Progress in MS Treatment:

Illustrations in Ulcerative Colitis

ADVANCED PARKINSON'S DISEASE:

Advancing the Treatment of IBD With Biologics

Treating to Target in MS

EARLY Combination Therapy in PAH: What Every Cardiologist Needs to Know.

Oral Prostanoids and PAH

Program Goals Overview Is NEDA a Reasonable Target?

Managing Age-Related Clinical Issues in Hemophilia

Treatment of Locally Advanced Pancreatic Cancer

Program Goals Disclaimers Defining Refractory Seizures.

Optimizing Targeted Therapy for HER2-Positive Advanced Breast Cancer: Considerations for Previously Treated Disease.

Managing Patients with Relapsed CLL who Discontinue BCR Signaling Inhibitors.

NEDA 2-Year Endpoint: Not a Predictor of Long-Term Stability?

Are We Making Progress in the Management of Huntington Disease?

Bone Biology and Osteoporosis: Back to the Basics

Pregnancy in MS.

Communicating With Your Patients About Major Depressive Disorder

Incorporating Prostacyclins Into Practice

Approximate Dose Equivalency of Statin LDL-C Efficacy.

Essential Updates for PsA: A Complex Disease to Manage

Improving Adherence to Antiplatelet Therapy After an ACS Event

A Multidisciplinary Perspective on the Management of Hypoparathyroidism.

Background. Current Perspectives on the Management of Iron Deficiency in Chronic Heart Failure.

Clinical Challenges and Updates in Managing Seizure Clusters

What You Need To Know To Effectively Manage Patients With MDD Key Terms (cont)

Clinical Challenges in the Patient With Relapsed Multiple Myeloma

MS, Age, and Immune Function

NAFLD and NASH in Europe and Canada

Ask the Psoriasis Expert

Understanding the Role of Disability in MS Management

Navigating the Journey

Fresh perspectives ON BASAL Insulins in diabetes care

Presentation transcript:

Program Goals

Overview

Is NEDA a Reasonable Target?

Treatment Strategies

Induction Strategies

Should RIS Be Treated?

MS as a Spectrum Disease

Addressing Relapsing Disease

Addressing Cognitive Impairment

Patient Management Strategies: Communicating About Risk

Combination Therapy

Potential Role of Hormones: Estriol Reduced Relapse Rates

Potential Role of Hormones (cont): Testosterone Offers Neuroprotection

Vitamin D Supplementation

A Holistic Approach

On the Horizon

Summary and Key Points

Abbreviations

References

References (cont)